The investigation of antioxidant and anti-inflammatory potentials of apitherapeutic agents on heart tissues in nitric oxide synthase inhibited rats via Nω-nitro-L-arginine methyl ester. (2nd January 2021)
- Record Type:
- Journal Article
- Title:
- The investigation of antioxidant and anti-inflammatory potentials of apitherapeutic agents on heart tissues in nitric oxide synthase inhibited rats via Nω-nitro-L-arginine methyl ester. (2nd January 2021)
- Main Title:
- The investigation of antioxidant and anti-inflammatory potentials of apitherapeutic agents on heart tissues in nitric oxide synthase inhibited rats via Nω-nitro-L-arginine methyl ester
- Authors:
- Ozdemir, Betul
Gulhan, Mehmet Fuat
Sahna, Engin
Selamoglu, Zeliha - Abstract:
- ABSTRACT: Background: High blood pressure effects heart and vessels. Development of pathogenesis is the result of oxidative stress. We aimed to investigate the antioxidant effects of propolis, caffeic acid phenethyl ester (CAPE), and pollen on the hearts of rats which chronic nitric oxide synthase (NOS) inhibited through Nω-nitro-L-arginine methyl ester (L-NAME). Paraoxonase 1 (PON1), total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), asymmetric dimethylarginine (ADMA), and nuclear factor-κB (NF-κB) were analyzed on the heart. Material and Methods: Sprague-Dawley rats were divided five groups of seven rats in every group; Group I: Control, Group II: L-NAME, Group III: L-NAME+propolis, Group IV: L-NAME+CAPE and Group V: L-NAME+pollen. L-NAME become dissolved in regular saline (0.9% NaCl w/v). The ethanolic extract of propolis (200 mg/kg/days, gavage), pollen (100 mg/kg/days, by gavage), CAPE (50 µM/kg/days, intraperitoneally), and the NOS inhibitor L-NAME (40 mg/kg, intraperitoneally) had been administered. Results: Blood pressure (BP) of rats treated with propolis, CAP, E and pollen statistically significant decreased. Decreasing in BP of the rats of pollen group was more than CAPE and propolis groups ( P < .05). PON1 and TAS levels decreased in L-NAME-treated groups ( P < .05), but ranges have been better in propolis, CAPE and pollen groups. TOS, ADMA and NF-κB levels increased ( P < .05) in L-NAME group; however, these parameters wereABSTRACT: Background: High blood pressure effects heart and vessels. Development of pathogenesis is the result of oxidative stress. We aimed to investigate the antioxidant effects of propolis, caffeic acid phenethyl ester (CAPE), and pollen on the hearts of rats which chronic nitric oxide synthase (NOS) inhibited through Nω-nitro-L-arginine methyl ester (L-NAME). Paraoxonase 1 (PON1), total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), asymmetric dimethylarginine (ADMA), and nuclear factor-κB (NF-κB) were analyzed on the heart. Material and Methods: Sprague-Dawley rats were divided five groups of seven rats in every group; Group I: Control, Group II: L-NAME, Group III: L-NAME+propolis, Group IV: L-NAME+CAPE and Group V: L-NAME+pollen. L-NAME become dissolved in regular saline (0.9% NaCl w/v). The ethanolic extract of propolis (200 mg/kg/days, gavage), pollen (100 mg/kg/days, by gavage), CAPE (50 µM/kg/days, intraperitoneally), and the NOS inhibitor L-NAME (40 mg/kg, intraperitoneally) had been administered. Results: Blood pressure (BP) of rats treated with propolis, CAP, E and pollen statistically significant decreased. Decreasing in BP of the rats of pollen group was more than CAPE and propolis groups ( P < .05). PON1 and TAS levels decreased in L-NAME-treated groups ( P < .05), but ranges have been better in propolis, CAPE and pollen groups. TOS, ADMA and NF-κB levels increased ( P < .05) in L-NAME group; however, these parameters were lower ( P < .05) in propolis and CAPE groups ( P < .05). Conclusions: Vasorelaxant properties and free radical scavenging actions of propolis, CAPE, and pollen may reduce the oxidative stress and blood pressure in the rats chronic NOS inhibited through L-NAME. … (more)
- Is Part Of:
- Clinical and experimental hypertension. Volume 43:Number 1(2021)
- Journal:
- Clinical and experimental hypertension
- Issue:
- Volume 43:Number 1(2021)
- Issue Display:
- Volume 43, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 43
- Issue:
- 1
- Issue Sort Value:
- 2021-0043-0001-0000
- Page Start:
- 69
- Page End:
- 76
- Publication Date:
- 2021-01-02
- Subjects:
- Anti-inflammatory effect -- antioxidant -- apitheraphy -- heart -- hypertension -- oxidative stress -- rat
Hypertension -- Chemotherapy -- Periodicals
Hypotensive agents -- Periodicals
616.132 - Journal URLs:
- http://informahealthcare.com/loi/ceh ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/10641963.2020.1806294 ↗
- Languages:
- English
- ISSNs:
- 1064-1963
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.250500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 15267.xml